Menu
Search
|

Menu

Close
X

Pacific Biosciences of California Inc PACB.OQ (NASDAQ Stock Exchange Global Select Market)

4.38 USD
-0.13 (-2.88%)
As of Oct 19
chart
Previous Close 4.51
Open 4.58
Volume 280,875
3m Avg Volume 277,250
Today’s High 4.84
Today’s Low 4.38
52 Week High 5.82
52 Week Low 2.03
Shares Outstanding (mil) 115.59
Market Capitalization (mil) 564.09
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.67 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
41
FY17
93
FY16
91
FY15
93
EPS (USD)
FY18
-0.366
FY17
-0.888
FY16
-0.837
FY15
-0.427
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.65
Price to Sales (TTM)
vs sector
5.89
5.82
Price to Book (MRQ)
vs sector
4.87
4.89
Price to Cash Flow (TTM)
vs sector
--
22.93
Total Debt to Equity (MRQ)
vs sector
11.29
17.17
LT Debt to Equity (MRQ)
vs sector
9.01
12.75
Return on Investment (TTM)
vs sector
-63.71
14.28
Return on Equity (TTM)
vs sector
-76.75
16.00

EXECUTIVE LEADERSHIP

Michael Hunkapiller
Chairman of the Board, President, Chief Executive Officer, Since 2012
Salary: $1.00
Bonus: --
Susan Barnes
Chief Financial Officer, Executive Vice President, Since 2010
Salary: $1.00
Bonus: --
Kathy Ordonez
Executive Vice President and Chief Commercial Officer and Director, Since 2017
Salary: $1.00
Bonus: --
James Phillips
Senior Vice President - Research and Development, Since 2010
Salary: $336,800.00
Bonus: $24,515.00
William Ericson
Lead Independent Director, Since 2010
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

1305 O'brien Drive
MENLO PARK   CA   94025

Phone: +1650.5218000

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

SPONSORED STORIES